Sector ratings Legend Biotech Corporation

Equities

Real-time Estimate Cboe BZX Other stock markets 14:37:57 15/12/2025 GMT			5-day change	1st Jan Change
22.46 ^USD	+0.60%		-20.65%	-31.41%

12-10	Legend Biotech's Stock Weakness After Rival Treatment Update 'Overdone,' RBC Says	MT
12-08	UBS Adjusts Legend Biotech Price Target to $48 From $54, Maintains Buy Rating	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Financial revisions	Global Valuation	Visibility	Consensus
LEGEND BIOTECH CORPORATION	4.12B	-	BB	-		-
ARGENX SE	54.11B		AA
INSMED INCORPORATED	42.02B	-	BBB	-		-
WUXI APPTEC CO., LTD.	39.6B		AAA
BIONTECH SE	22.8B	-	-	-		-
GENMAB A/S	19.5B		AA
WUXI BIOLOGICS (CAYMAN) INC.	17.76B		AAA
AKESO, INC.	14.73B		B			-
SUMMIT THERAPEUTICS INC.	13.55B	-	-	-		-
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	13.14B	-	A	-		-
MADRIGAL PHARMACEUTICALS, INC.	12.98B	-	B	-		-
SAMSUNG EPIS HOLDINGS CO., LTD.	11.13B	-	-	-	-	-	-	-
EXELIXIS, INC.	11B		BB
ARROWHEAD PHARMACEUTICALS, INC.	9.52B	-	BBB	-		-
TRANSTHERA SCIENCES (NANJING), INC.	8.19B	-	-	-	-	-	-	-
CEREVEL THERAPEUTICS HOLDINGS, INC.	8.19B	-	-	-	-	-	-	-
NUVALENT, INC.	8.14B	-	CCC	-		-
CYTOKINETICS, INCORPORATED	7.75B	-	AA	-		-
METSERA, INC.	7.43B	-	B	-	-	-	-
MERUS N.V.	7.35B	-	BBB	-		-
Average	16.65B		A
Weighted average by Cap.			A